Cj Cheiljedang Corporation

Korea Institute of Science and Technology

Cj Cheijedang Corporation

Young Wook Cho

Soo An Shin

Hyang Choi

Si Yong Yang

Min Tae Park

In Hye Kang

Eun Mi Shin

So Young Kim

So-Young Kim

Jae Won Kim

Holly J Jessen

Hye Won Um

Jin Sook Chang

Wei Niu

Su Jin Choi

Kwang Ho Na

Fernando A Sanchez-Riera

Kwang Myung Cho

In Kyung Heo

Han Jin Lee

Brian J Brazeau

Chul Ha Kim

Yong-Uk Shin

Jin-Sook Chang

Hyewon Um

Mervyn Desouza

Young Uk Shin

Young Sa Kim

Sang Wook Han

Chang Il Seo

Sung Wook Moon

Yong Su Kim

Ji Woong Choi

Sang Yun Lee

Min Sung Kang

Chang Ii Seo

Ho Joong Jung

Seung Woo Jeon

Hyang Tag Lim

An inverted nanocone structure of the present disclosure includes a first surface, a second surface spaced apart from the first surface by a predetermined distance and having a greater area than the first surface, and a body having an inverted cone shape between the first surface and the second surface, wherein at least one activated point defect center is provided in the body.

Inverted nanocone structure for optical device and method of producing the same

This specification discloses a quantum public-key cryptosystem. The quantum public-key cryptosystem may use two rotation operators R(&#x3b8;) and R(&#x3c6;) satisfying a cyclic evolution. The two rotation operators R(&#x3b8;) and R(&#x3c6;) do not have a commutation relation or an anti-commutation relation with each other. The commutation relation or the anti-commutation relation is established when either of the following conditions is satisfied: &#x3b8;=2i&#x3c0;, &#x3c6;=2j&#x3c0;, or {circumflex over (n)}&#xb7;{circumflex over (m)}=1 (i, j=integer), and &#x3b8;=(2k+1)&#x3c0;, &#x3c6;=(2l+1)&#x3c0;, or {circumflex over (n)}&#xb7;{circumflex over (m)}=0 (k, l=integer).

Quantum signature method and quantum secret sharing method using quantum trapdoor one-way function

The present invention relates to a bacteriophage having a specific bactericidal activity against, a composition for the prevention or treatment of infectious diseases comprising the bacteriophage as an active ingredient, an antibiotic comprising the bacteriophage as an active ingredient, an animal feed or drinking water comprising the bacteriophage as an active ingredient, and a sanitizer or cleaner comprising the bacteriophage as an active ingredient. The bacteriophage of the present invention has a specific bactericidal activity againstorwith no influences on beneficial bacteria, as well as excellent acid- and heat-resistance and desiccation tolerance.

Bacteriophage and antibacterial composition comprising the same

The present invention relates to a bacteriophage having a specific bactericidal activity against, a composition for the prevention or treatment of infectious diseseases comprising the bacteriophage as an active ingredient, an antibiotic comprising the bacteriophage as an active ingredient, an animal feed or drinking water comprising the bacteriophage as an active ingredient, and a sanitizer or cleaner comprising the bacteriophage as an active ingredient. The bacteriophage of the present nvention has a specific bactericidal activity against, orwith no influences on beneficial bacteria, as well as excellent acid- and heat-resistance and desiccation tolerance. Therefore, the bacteriophage can be used for the prevention or treatment of salmonellosis orfood poisoning, which is an infection disease cuased by, or, and also widely used in animal feeds, drinking water for livestock, sanitizers, and cleaners.

Described herein are microorganisms that produce methionine and related products from endogenous genes in a transsulfuration pathway, as well as from exogenous genes providing a direct sulfhydrylation pathway. Novel genes that are useful for methionine and SAMe production are disclosed.

Compositions and methods of producing methionine

The present invention relates to a novel bacteriophage having an-specific bactericidal activity, a composition for the prevention or treatment of infectious diseases caused by Enterotoxigeniccomprising the bacteriophage as an active ingredient, an antibiotic comprising the bacteriophage as an active ingredient, a feed additive composition comprising the bacteriophage as an active ingredient, a sanitizer or cleaner comprising the bacteriophage as an active ingredient, and a method for treating colibacillosis using the bacteriophage. The novel bacteriophage of the present invention has a specific bactericidal activity against pathogenic, and excellent acid- and heat-resistance. Therefore, the novel bacteriophage can be used for the prevention or treatment of swine colibacillosis, which is an infectious disease caused by pathogenic, and can also be widely used in animal feed additive compositions, sanitizers, and cleaners.

[object Object]

The present invention relates to avirulentvariants by inactivating virulence gene clusters of(SG), a main pathogen of avian salmonellosis, and various uses thereof notably in the production of-specific lytic bacteriophages, pharmaceutical compositions and feed additives.

The present invention relates to a microorganism producing L-methionine precursor, O-acetylhomoserine, and a method of producing L-methionine precursor using the microorganism.

Microorganism producing L-methionine precursor and the method of producing L-methionine precursor using the microorganism

Disclosed herein is a novel bacteriophage which has specific bactericidal activity against one or morebacteria selected from the group consisting of, andwithout affecting beneficial bacteria, in addition to showing excellent tolerance to acid, heat and desiccation. The novel bacteriophage of the present invention can be widely used as an active ingredient for therapeutic agents, animal feeds or drinking water, cleaners and sanitizers for preventing and treating the infectious diseases caused byorincluding salmonellosis,food poisoning, Fowl Typhoid, and Pullorum disease or for controlling thebacteria. The present invention also provides important insights into prevention and control strategies againstinfection and suggests that the use of bacteriophage can be a novel, safe, and effectively plausible alternative to antibiotics for the prevention ofinfection in poultry.

The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity against, or, a composition for the prevention or treatment of infectious diseases including salmonellosis andfood poisoning caused by, Fowl typhoid caused by, and Pullorum disease caused by, which comprises the bacteriophage as an active ingredient, and an animal feed, drinking water, cleaner, and sanitizer which comprise the bacteriophage as an active ingredient. The present invention also provides important insights into prevention and control strategies againstinfection and suggests that the use of bacteriophage can be a novel, safe, and effectively plausible alternative to antibiotics for the prevention ofinfection in poultry.

The present invention relates to a novel bacteriophage, more particularly, a bacteriophage that has a specific bactericidal activity againstand, a composition for the prevention or treatment of infectious diseases including salmonellosis andfood poisoning caused byor, Fowl typhoid caused by, and Pullorum disease caused bypullorum, which comprises the bacteriophage as an active ingredient, and an animal feed, drinking water, cleaner, and sanitizer which comprise the bacteriophage as an active ingredient.

Bacteriophage of the siphoviridae family and antibacterial compositions comprising the same

Growing community of inventors

Seoul, South Korea

Young Wook Cho